Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
40
NTRA Quote, Financials, Valuation and Earnings
Last price:
$202.91
Seasonality move
:
16.85%
Day range:
$192.60 - $210.51
52-week range:
$125.38 - $256.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.30x
P/B ratio:
16.86x
Volume:
1.5M
Avg. volume:
1.2M
1-year change:
44.67%
Market cap:
$28.9B
Revenue:
$2.3B
EPS (TTM):
-$1.54
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NTRA
Natera, Inc.
|
$600.7M | -$0.53 | 22.54% | -18.95% | $260.15 |
|
DCTH
Delcath Systems, Inc.
|
$20.7M | -$0.03 | 19.07% | -44.65% | $21.33 |
|
EXAS
EXACT Sciences Corp.
|
$860.8M | $0.08 | 18.03% | -84.17% | $105.81 |
|
GH
Guardant Health, Inc.
|
$272.3M | -$0.47 | 37.47% | -38.38% | $132.57 |
|
ILMN
Illumina, Inc.
|
$1.1B | $1.23 | 3.09% | 28.5% | $136.05 |
|
WGS
GeneDx Holdings Corp.
|
$120.4M | $0.12 | 29.38% | -92.82% | $156.67 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NTRA
Natera, Inc.
|
$207.04 | $260.15 | $28.9B | -- | $0.00 | 0% | 12.30x |
|
DCTH
Delcath Systems, Inc.
|
$8.60 | $21.33 | $298.4M | 136.94x | $0.00 | 0% | 3.94x |
|
EXAS
EXACT Sciences Corp.
|
$103.37 | $105.81 | $19.7B | -- | $0.00 | 0% | 6.01x |
|
GH
Guardant Health, Inc.
|
$93.30 | $132.57 | $12.2B | -- | $0.00 | 0% | 11.91x |
|
ILMN
Illumina, Inc.
|
$129.56 | $136.05 | $19.8B | 23.71x | $0.00 | 0% | 4.66x |
|
WGS
GeneDx Holdings Corp.
|
$76.97 | $156.67 | $2.3B | 1,444.11x | $0.00 | 0% | 5.21x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NTRA
Natera, Inc.
|
11.13% | 1.083 | 0.67% | 3.13x |
|
DCTH
Delcath Systems, Inc.
|
0.84% | 1.693 | 0.27% | 9.39x |
|
EXAS
EXACT Sciences Corp.
|
51.36% | 1.148 | 13.08% | 1.97x |
|
GH
Guardant Health, Inc.
|
106.17% | 0.901 | 12.82% | 4.42x |
|
ILMN
Illumina, Inc.
|
48.39% | 1.884 | 12.72% | 1.59x |
|
WGS
GeneDx Holdings Corp.
|
26.86% | 3.234 | 2.98% | 2.26x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NTRA
Natera, Inc.
|
$443.7M | -$18.9M | -13.63% | -15.66% | -2.84% | $17.3M |
|
DCTH
Delcath Systems, Inc.
|
$17.7M | -$2.2M | 2.78% | 2.81% | -10.54% | $7.7M |
|
EXAS
EXACT Sciences Corp.
|
$615.8M | -$76.7M | -4.14% | -8.54% | -8.73% | $120.4M |
|
GH
Guardant Health, Inc.
|
$181.8M | -$120.3M | -35.5% | -8518.58% | -42.76% | -$41.9M |
|
ILMN
Illumina, Inc.
|
$778M | $257M | 16.96% | 35.12% | 22.16% | $263M |
|
WGS
GeneDx Holdings Corp.
|
$78.9M | -$13.7M | -5.37% | -7.62% | -11.34% | -$7.4M |
Natera, Inc. vs. Competitors
-
Which has Higher Returns NTRA or DCTH?
Delcath Systems, Inc. has a net margin of 7.1% compared to Natera, Inc.'s net margin of -9.15%. Natera, Inc.'s return on equity of -15.66% beat Delcath Systems, Inc.'s return on equity of 2.81%.
Company Gross Margin Earnings Per Share Invested Capital NTRANatera, Inc.66.67% $0.34 $1.9B DCTHDelcath Systems, Inc.85.48% -$0.05 $112.2M -
What do Analysts Say About NTRA or DCTH?
Natera, Inc. has a consensus price target of $260.15, signalling upside risk potential of 25.65%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $21.33 which suggests that it could grow by 148.06%. Given that Delcath Systems, Inc. has higher upside potential than Natera, Inc., analysts believe Delcath Systems, Inc. is more attractive than Natera, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NTRANatera, Inc.13 2 0 DCTHDelcath Systems, Inc.5 0 0 -
Is NTRA or DCTH More Risky?
Natera, Inc. has a beta of 1.647, which suggesting that the stock is 64.678% more volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.377, suggesting its less volatile than the S&P 500 by 62.293%.
-
Which is a Better Dividend Stock NTRA or DCTH?
Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NTRA or DCTH?
Natera, Inc. quarterly revenues are $665.5M, which are larger than Delcath Systems, Inc. quarterly revenues of $20.7M. Natera, Inc.'s net income of $47.3M is higher than Delcath Systems, Inc.'s net income of -$1.9M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Delcath Systems, Inc.'s PE ratio is 136.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 12.30x versus 3.94x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NTRANatera, Inc.12.30x -- $665.5M $47.3M DCTHDelcath Systems, Inc.3.94x 136.94x $20.7M -$1.9M
-
Which has Higher Returns NTRA or EXAS?
EXACT Sciences Corp. has a net margin of 7.1% compared to Natera, Inc.'s net margin of -9.79%. Natera, Inc.'s return on equity of -15.66% beat EXACT Sciences Corp.'s return on equity of -8.54%.
Company Gross Margin Earnings Per Share Invested Capital NTRANatera, Inc.66.67% $0.34 $1.9B EXASEXACT Sciences Corp.70.11% -$0.45 $4.9B -
What do Analysts Say About NTRA or EXAS?
Natera, Inc. has a consensus price target of $260.15, signalling upside risk potential of 25.65%. On the other hand EXACT Sciences Corp. has an analysts' consensus of $105.81 which suggests that it could grow by 2.36%. Given that Natera, Inc. has higher upside potential than EXACT Sciences Corp., analysts believe Natera, Inc. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings NTRANatera, Inc.13 2 0 EXASEXACT Sciences Corp.1 20 0 -
Is NTRA or EXAS More Risky?
Natera, Inc. has a beta of 1.647, which suggesting that the stock is 64.678% more volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.415, suggesting its more volatile than the S&P 500 by 41.517%.
-
Which is a Better Dividend Stock NTRA or EXAS?
Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NTRA or EXAS?
Natera, Inc. quarterly revenues are $665.5M, which are smaller than EXACT Sciences Corp. quarterly revenues of $878.4M. Natera, Inc.'s net income of $47.3M is higher than EXACT Sciences Corp.'s net income of -$86M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 12.30x versus 6.01x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NTRANatera, Inc.12.30x -- $665.5M $47.3M EXASEXACT Sciences Corp.6.01x -- $878.4M -$86M
-
Which has Higher Returns NTRA or GH?
Guardant Health, Inc. has a net margin of 7.1% compared to Natera, Inc.'s net margin of -45.68%. Natera, Inc.'s return on equity of -15.66% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital NTRANatera, Inc.66.67% $0.34 $1.9B GHGuardant Health, Inc.64.63% -$1.00 $1.6B -
What do Analysts Say About NTRA or GH?
Natera, Inc. has a consensus price target of $260.15, signalling upside risk potential of 25.65%. On the other hand Guardant Health, Inc. has an analysts' consensus of $132.57 which suggests that it could grow by 42.09%. Given that Guardant Health, Inc. has higher upside potential than Natera, Inc., analysts believe Guardant Health, Inc. is more attractive than Natera, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NTRANatera, Inc.13 2 0 GHGuardant Health, Inc.17 2 0 -
Is NTRA or GH More Risky?
Natera, Inc. has a beta of 1.647, which suggesting that the stock is 64.678% more volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.673, suggesting its more volatile than the S&P 500 by 67.29%.
-
Which is a Better Dividend Stock NTRA or GH?
Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NTRA or GH?
Natera, Inc. quarterly revenues are $665.5M, which are larger than Guardant Health, Inc. quarterly revenues of $281.3M. Natera, Inc.'s net income of $47.3M is higher than Guardant Health, Inc.'s net income of -$128.5M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 12.30x versus 11.91x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NTRANatera, Inc.12.30x -- $665.5M $47.3M GHGuardant Health, Inc.11.91x -- $281.3M -$128.5M
-
Which has Higher Returns NTRA or ILMN?
Illumina, Inc. has a net margin of 7.1% compared to Natera, Inc.'s net margin of 28.79%. Natera, Inc.'s return on equity of -15.66% beat Illumina, Inc.'s return on equity of 35.12%.
Company Gross Margin Earnings Per Share Invested Capital NTRANatera, Inc.66.67% $0.34 $1.9B ILMNIllumina, Inc.67.07% $2.17 $5.3B -
What do Analysts Say About NTRA or ILMN?
Natera, Inc. has a consensus price target of $260.15, signalling upside risk potential of 25.65%. On the other hand Illumina, Inc. has an analysts' consensus of $136.05 which suggests that it could grow by 5.01%. Given that Natera, Inc. has higher upside potential than Illumina, Inc., analysts believe Natera, Inc. is more attractive than Illumina, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NTRANatera, Inc.13 2 0 ILMNIllumina, Inc.8 8 1 -
Is NTRA or ILMN More Risky?
Natera, Inc. has a beta of 1.647, which suggesting that the stock is 64.678% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.453, suggesting its more volatile than the S&P 500 by 45.278%.
-
Which is a Better Dividend Stock NTRA or ILMN?
Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NTRA or ILMN?
Natera, Inc. quarterly revenues are $665.5M, which are smaller than Illumina, Inc. quarterly revenues of $1.2B. Natera, Inc.'s net income of $47.3M is lower than Illumina, Inc.'s net income of $334M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while Illumina, Inc.'s PE ratio is 23.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 12.30x versus 4.66x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NTRANatera, Inc.12.30x -- $665.5M $47.3M ILMNIllumina, Inc.4.66x 23.71x $1.2B $334M
-
Which has Higher Returns NTRA or WGS?
GeneDx Holdings Corp. has a net margin of 7.1% compared to Natera, Inc.'s net margin of -14.6%. Natera, Inc.'s return on equity of -15.66% beat GeneDx Holdings Corp.'s return on equity of -7.62%.
Company Gross Margin Earnings Per Share Invested Capital NTRANatera, Inc.66.67% $0.34 $1.9B WGSGeneDx Holdings Corp.65.23% -$0.61 $421.4M -
What do Analysts Say About NTRA or WGS?
Natera, Inc. has a consensus price target of $260.15, signalling upside risk potential of 25.65%. On the other hand GeneDx Holdings Corp. has an analysts' consensus of $156.67 which suggests that it could grow by 103.54%. Given that GeneDx Holdings Corp. has higher upside potential than Natera, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Natera, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NTRANatera, Inc.13 2 0 WGSGeneDx Holdings Corp.8 0 0 -
Is NTRA or WGS More Risky?
Natera, Inc. has a beta of 1.647, which suggesting that the stock is 64.678% more volatile than S&P 500. In comparison GeneDx Holdings Corp. has a beta of 2.031, suggesting its more volatile than the S&P 500 by 103.067%.
-
Which is a Better Dividend Stock NTRA or WGS?
Natera, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GeneDx Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Natera, Inc. pays -- of its earnings as a dividend. GeneDx Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NTRA or WGS?
Natera, Inc. quarterly revenues are $665.5M, which are larger than GeneDx Holdings Corp. quarterly revenues of $121M. Natera, Inc.'s net income of $47.3M is higher than GeneDx Holdings Corp.'s net income of -$17.7M. Notably, Natera, Inc.'s price-to-earnings ratio is -- while GeneDx Holdings Corp.'s PE ratio is 1,444.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Natera, Inc. is 12.30x versus 5.21x for GeneDx Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NTRANatera, Inc.12.30x -- $665.5M $47.3M WGSGeneDx Holdings Corp.5.21x 1,444.11x $121M -$17.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
46
ZD alert for Mar 4
Ziff Davis, Inc. [ZD] is up 3.64% over the past day.
Buy
54
KORU alert for Mar 4
Direxion Daily MSCI South Korea Bull 3X Shares [KORU] is up 5.43% over the past day.
Sell
40
PSIX alert for Mar 4
Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.
